PBH vs. ESLOY: Which Stock Should Value Investors Buy Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
- 05/14/2025
|
Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q4 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Phil Terpolilli – Vice President, Investor Relations and Treasury Ron Lombardi – Chairman, President and Chief Executive Officer Christine Sacco – Chief Financial Officer and Chief Operating Officer Conference Call Participants Rupesh Parikh – Oppenheimer Susan Anderson – Canaccord Keith Devas – Jefferies Glenn West – William Blair Anthony Lebiedzinski – Sidoti & Company Doug Lane – Water Tower Research Operator Good day, and thank you for standing by. Welcome to the Prestige Consumer Healthcare's Fourth Quarter 2025 Earnings Conference Call.
- 05/11/2025
|
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates
- Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.30 per share. This compares to earnings of $1.02 per share a year ago.
- 05/08/2025
|
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
- TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.
- 05/08/2025
|
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
- TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.
- 05/08/2025
|
PBH or ABT: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/28/2025
|
Premium Brands Holdings Corporation to Release First Quarter 2025 Results
- Vancouver, British Columbia--(Newsfile Corp. - April 24, 2025) - Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its first quarter 2025 results on Wednesday, May 7, 2025. Pre-recorded Management Remarks, Press Release and Investor Presentation Please note that management's pre-recorded remarks, a press release including financial statements and segment information and an investor presentation will be available on the morning of Wednesday, May 7, 2025 at 4:00 a.m.
- 04/24/2025
|
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
- Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
- 04/17/2025
|
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
- TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
- 04/10/2025
|
PBH vs. SYK: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
- 04/10/2025
|
Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock?
- PBH's shares rise on the back of its portfolio of consumer brands and focus on core strategies to achieve long-term success.
- 03/27/2025
|
Should You Consider Retaining PBH Stock in Your Portfolio Now?
- Investors remain optimistic about Prestige Consumer due to its strong focus on brand building and strategic acquisition.
- 03/25/2025
|
Premium Brands Holdings Corporation Announces $150 Million Financing of Convertible Unsecured Subordinated Debentures
- NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 05, 2025 (GLOBE NEWSWIRE) -- Premium Brands Holdings Corporation (“Premium Brands” or the “Company”) (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, is pleased to announce it has entered into an agreement with a syndicate of underwriters co-led by CIBC Capital Markets, National Bank Financial, BMO Capital Markets and Scotiabank (collectively, the “Underwriters”), pursuant to which the Company will issue on a “bought-deal” basis, subject to regulatory approval, $150,000,000 aggregate principal amount of convertible unsecured subordinated debentures (the “Debentures”) at a price of $1,000 per Debenture (the “Offering”). The Company has also granted the Underwriters an over-allotment option to purchase up to an additional $22,500,000 aggregate principal amount of Debentures, on the same terms, exercisable in whole or in part at any time for a period of up to 30 days following closing of the Offering, to cover over-allotments, if any.
- 03/05/2025
|
PBH or BSX: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
- 02/17/2025
|
PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%
- Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.
- 02/07/2025
|
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Company Susan Anderson - Canaccord Genuity Keith Devas - Jefferies David Shakno - William Blair Linda Bolton Weiser - D. A. Davidson Anthony Lebiedzinski - Sidoti & Company Operator Thank you for standing by, and welcome to Prestige Consumer Healthcare's Third Quarter 2025 Earnings Conference Call.
- 02/06/2025
|
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates
- Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago.
- 02/06/2025
|
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
- TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024.
- 02/06/2025
|
PBH vs. BSX: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
- 01/31/2025
|
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge?
- PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.
- 01/22/2025
|
PBH or BSX: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
- 01/15/2025
|
PBH vs. BSX: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
- 12/30/2024
|
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
- Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
- 12/30/2024
|
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
- Investors remain optimistic about PBH stock due to its strong focus on brand building.
- 12/26/2024
|
PBH or ABT: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the better value opportunity right now?
- 12/13/2024
|
Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border
- Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a portfolio mix of proteins, baked goods, and distribution, with 70% sales from foodservice and retail chains. The macro environment suggests lower interest rates, but inflation and wage increases could impact PBH's middle and low-income customer base.
- 12/06/2024
|
PBH or SYK: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 11/27/2024
|
PBH vs. SYK: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 11/11/2024
|
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript
- Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Anthony Lebiedzinski - Sidoti & Co. Operator Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
- 11/09/2024
|
PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise
- Prestige Consumer Healthcare's second-quarter sales are impacted by the ongoing supply chain challenges in the Clear Eyes business.
- 11/08/2024
|
Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates
- Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.07 per share a year ago.
- 11/07/2024
|
PBH or SYK: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
- 10/23/2024
|
PBH vs. SYK: Which Stock Is the Better Value Option?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/07/2024
|
PBH or SYK: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
- 09/20/2024
|
What Makes Prestige Consumer Healthcare (PBH) a Good Fit for 'Trend Investing'
- Prestige Consumer Healthcare (PBH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
- 09/20/2024
|
PBH or SYK: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
- 09/04/2024
|
Here's Why 'Trend' Investors Would Love Betting on Prestige Consumer Healthcare (PBH)
- Prestige Consumer Healthcare (PBH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
- 09/04/2024
|
Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Phil Terpolilli - Director of IR Ron Lombardi - Chairman, President & CEO Chris Sacco - CFO Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Linda Bolton-Weiser - D.A. Davidson Anthony Lebiedzinski - Sidoti & Co. Mitchell Pinheiro - Sturdivant Trevor Sahr - William Blair Operator Welcome to the Q1 2025 Prestige Consumer Healthcare Inc. Earnings Conference Call.
- 08/08/2024
|
Prestige Consumer Healthcare (PBH) Reports Q1 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/08/2024
|
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
- TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2024.
- 08/08/2024
|
AHCO or PBH: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of AdaptHealth Corp. (AHCO) and Prestige Consumer Healthcare (PBH). But which of these two stocks is more attractive to value investors?
- 07/09/2024
|
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
- TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
- 07/02/2024
|
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
- TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on Monday, June 10, 2024 at 1:30 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
- 06/06/2024
|
Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
- Prestige Consumer's (PBH) Q4 business suffers from supply chain pressure that impacts its ability to fulfill retailer orders.
- 05/16/2024
|
Prestige Consumer Healthcare Inc (PBH) Q4 2024 Earnings Call Transcript
- Prestige Consumer Healthcare Inc (NYSE:PBH ) Q4 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Phil Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President & CEO Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Mitchell Pinheiro - Sturdivant Linda Bolton-Weiser - D.A. Davidson Operator Thank you for standing by.
- 05/15/2024
|
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 05/14/2024
|
Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates
- Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.07 per share a year ago.
- 05/14/2024
|
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
- TARRYTOWN, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2024.
- 05/14/2024
|
2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
- Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
- 05/13/2024
|
Unveiling Prestige Consumer Healthcare (PBH) Q4 Outlook: Wall Street Estimates for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
- 05/09/2024
|
PBH vs. ABT: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/30/2024
|
Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
- Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/25/2024
|
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
- TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close. The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m. ET.
- 04/25/2024
|
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
- The robust strength of Prestige Consumer's (PBH) diversified portfolio bodes well for investors.
- 04/19/2024
|
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/08/2024
|
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
- The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags
- 04/03/2024
|
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
- Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.
- 04/02/2024
|
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/25/2024
|
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/21/2024
|
Reasons to Retain Prestige Consumer (PBH) Stock for Now
- Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
- 03/05/2024
|
Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 02/29/2024
|
Prestige Consumer (PBH) Q3 Earnings Top, Gross Margin Expands
- Prestige Consumer's (PBH) third-quarter fiscal 2024 results reflect the power of a well-positioned and diversified portfolio.
- 02/09/2024
|
Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript
- 02/08/2024
|
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/08/2024
|
Prestige Consumer Healthcare (PBH) Surpasses Q3 Earnings and Revenue Estimates
- Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.04 per share a year ago.
- 02/08/2024
|
PBH vs. BSX: Which Stock Should Value Investors Buy Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
- 02/02/2024
|
Prestige Consumer Healthcare (PBH) Reports Next Week: What Awaits?
- Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/01/2024
|
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024
- Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.
- 01/19/2024
|
PBH or BSX: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/17/2024
|
4 Medical Product Stocks to Buy Amid Industry Challenges
- Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. PHG, NEOG, HAE and PBH are well-poised to gain from the favorable factors.
- 01/08/2024
|
PBH vs. BSX: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
- 01/01/2024
|
Reasons to Buy Prestige Consumer (PBH) Stock for Now
- Investors remain optimistic about Prestige Consumer (PBH), backed by the robust strength of its consumer brands portfolio.
- 12/28/2023
|
PBH or BSX: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
- 12/15/2023
|
Prestige Consumer's (PBH) Brand Building, Innovation Aid Growth
- Prestige Consumer's (PBH) long-term brand-building efforts, efficient marketing, channel development and innovation help the company to continually hold a leading market share position.
- 11/15/2023
|
PBH vs. BSX: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
- 11/13/2023
|
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/08/2023
|
Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q2 2024 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Terpolilli - CFA Ron Lombardi - President and CEO Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Co Susan Anderson - Canaccord Genuity Jon Andersen - William Blair Keonhee Kim - Morningstar Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Prestige Consumer Healthcare Earnings Conference Call.
- 11/04/2023
|
Prestige Consumer (PBH) Q2 Revenues Top, Margins Expand
- Prestige Consumer's (PBH) second-quarter fiscal 2024 results benefit from a diverse brand portfolio and broad distribution.
- 11/03/2023
|
PBH or BSX: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/04/2023
|
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/22/2023
|
PBH vs. BSX: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
- 09/14/2023
|
Why Prestige Consumer Healthcare (PBH) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/11/2023
|
Down -11.27% in 4 Weeks, Here's Why You Should You Buy the Dip in Prestige Consumer Healthcare (PBH)
- The heavy selling pressure might have exhausted for Prestige Consumer Healthcare (PBH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 09/06/2023
|
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
- TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
- 09/05/2023
|
Prestige Consumer (PBH) Looks Well-Placed on Brand Strength
- Prestige Consumer (PBH) benefits from its solid brand portfolio and favorable demand. E-commerce growth has also been an upside.
- 09/05/2023
|
PBH vs. BSX: Which Stock Should Value Investors Buy Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?
- 08/29/2023
|
Looking for a Growth Stock? 3 Reasons Why Prestige Brands (PBH) is a Solid Choice
- Prestige Brands (PBH) possesses solid growth attributes, which could help it handily outperform the market.
- 08/16/2023
|
Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q1 2024 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Phil Terpolilli - VP, IR and Treasury Ron Lombardi - CEO Christine Sacco - CFO Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer & Co Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co. Operator Good day and thank you for standing by. Welcome to the Q1 2024 Prestige Consumer Healthcare, Inc. Earnings Conference Call.
- 08/05/2023
|
Prestige Brands (PBH) Reports Q1 Earnings: What Key Metrics Have to Say
- The headline numbers for Prestige Brands (PBH) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/03/2023
|
Factors to Note Ahead of Prestige Consumer's (PBH) Q1 Earnings
- Prestige Consumer's (PBH) first-quarter fiscal 2024 earnings are likely to have gained from business strength, brand-building strategies and robust e-commerce business. Rising costs and expenses might have dragged down its margins.
- 07/31/2023
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Lifetime Brands (LCUT) and Prestige Brands (PBH). But which of these two stocks is more attractive to value investors?
- 07/19/2023
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- Investors interested in Consumer Products - Discretionary stocks are likely familiar with Lifetime Brands (LCUT) and Prestige Brands (PBH). But which of these two stocks is more attractive to value investors?
- 06/16/2023
|
Prestige Consumer Healthcare to Present at Upcoming Investor Conferences
- TARRYTOWN, N.Y., June 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 6, 2023 at 1:00 p.m. ET. The following week, the Company will participate in a fireside chat at the Oppenheimer Consumer Growth & E-Commerce Conference virtually on Monday, June 12, 2023 at 9:45 a.m. ET.
- 06/05/2023
|
LCUT or PBH: Which Is the Better Value Stock Right Now?
- Investors interested in Consumer Products - Discretionary stocks are likely familiar with Lifetime Brands (LCUT) and Prestige Brands (PBH). But which of these two stocks offers value investors a better bang for their buck right now?
- 05/31/2023
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Lifetime Brands (LCUT) or Prestige Brands (PBH). But which of these two stocks presents investors with the better value opportunity right now?
- 05/15/2023
|
Prestige Consumer (PBH) Q4 Earnings Top Estimates, Revenues Up
- Prestige Consumer's (PBH) fourth-quarter fiscal 2023 results reflect gains from the company's diversified portfolio and brand-building efforts.
- 05/04/2023
|
Prestige Brands (PBH) Beats Q4 Earnings and Revenue Estimates
- Prestige Brands (PBH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $0.91 per share a year ago.
- 05/04/2023
|
What's in Store for Prestige Consumer (PBH) in Q4 Earnings?
- Prestige Consumer's (PBH) fourth-quarter fiscal 2023 earnings are likely to have gained from brand-building strategies and robust e-commerce business.
- 05/03/2023
|
PBH Stock: 7.06% Decrease This Week Explained
- The stock price of Prestige Consumer Healthcare Inc (NYSE: PBH) fell by 7.06% this past week. This is why.
- 02/04/2023
|
Prestige Consumer (PBH) Q3 Earnings & Revenues Top Estimates
- Prestige Consumer's (PBH) third-quarter fiscal 2023 results reflect strength in the Cough and Cold category and a solid International OTC segment performance.
- 02/03/2023
|
Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2023 Results Conference Call February 2, 2023 8:30 AM ET Company Participants Phil Terpolilli - Vice President of Investor Relations & Treasurer Ronald Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer and Company Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co Linda Bolton Weiser - D.A. Davidson Operator Good day and thank you for standing by.
- 02/02/2023
|
Prestige Brands (PBH) Q3 Earnings and Revenues Surpass Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 2.97% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2023
|
Prestige Consumer (PBH) to Post Q3 Earnings: Factors to Consider
- Prestige Consumer (PBH) third-quarter fiscal 2023 earnings might reflect gains from brand-building strategies, e-commerce business and market share gains.
- 01/27/2023
|
4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds
- Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.
- 11/07/2022
|
Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q2 2023 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - President and Chief Executive Officer Christine Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer & Co. Jon Andersen - William Blair Operator Good day and thank you for standing by. Welcome to the Prestige Consumer Healthcare Second Quarter Earnings Conference Call.
- 11/06/2022
|
Premium Brands Holdings Corporation (PRBZF) Q3 2022 Earnings Call Transcript
- Premium Brands Holdings Corporation (OTCPK:PRBZF) Q3 2022 Earnings Conference Call November 3, 2022 1:30 PM ET Company Participants George Paleologou - President & Chief Executive Officer Will Kalutycz - Chief Financial Officer Conference Call Participants Derek Lessard - TD Securities George Doumet - Scotiabank Martin Landry - Stifel GMP Stephen MacLeod - BMO Capital Markets John Zamparo - CIBC Capital Markets Vishal Shreedhar - National Bank Financial Kyle McPhee - Cormark Securities Derek Lessard - TD Securities Operator Good afternoon, ladies and gentlemen, and welcome to the Premium Brands Holdings Corporation Third Quarter 2022 Earnings Conference Call. At this time, all lines are in listen only mode.
- 11/05/2022
|
Prestige Consumer (PBH) Q2 Earnings Beat Mark, Revenues Rise
- Prestige Consumer's (PBH) second-quarter fiscal 2023 results were backed by strength in its brand portfolio and solid business strategy.
- 11/04/2022
|
Prestige Brands (PBH) Tops Q2 Earnings and Revenue Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 2% and 2.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/03/2022
|
Factors to Know Ahead of Prestige Consumer (PBH) Q2 Earnings
- Prestige Consumer's (PBH) second-quarter fiscal 2023 earnings results might reflect the impacts of a tough operating landscape, including supply-chain headwinds and higher costs.
- 11/01/2022
|
5 Stocks to Buy on Rise in Personal Income, Personal Spending
- Despite rising costs, people are spending aggressively as personal income is on the rise, helping stocks like Marriott Vacations (VAC), Hyatt Hotels (H), Prestige Consumer Healthcare (PBH), InterContinental Hotels (IHG) and Target Hospitality (TH).
- 10/03/2022
|
Here's Why Prestige Brands (PBH) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/28/2022
|
Consumer Confidence Soars for Second Straight Month: 4 Picks
- Stocks like Prestige Consumer Healthcare Inc. (PBH), RCI Hospitality Holdings, Inc. (RICK), Hyatt Hotels Corporation (H) and On Holding AG (ONON) may gain as Americans seem to be regaining their lost confidence.
- 09/28/2022
|
The 7 Most Undervalued Mid-Cap Stocks to Buy Now
- It's up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities are among stocks of the small-cap/”unknown” variety, there are also plenty of undervalued mid-cap stocks to buy now trading at low valuations.
- 09/26/2022
|
Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference
- TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
- 09/07/2022
|
Prestige Consumer (PBH) Brands & E-commerce Strength Bode Well
- Prestige Consumer Healthcare's (PBH) solid brand portfolio and e-commerce growth keep the company well-placed.
- 09/02/2022
|
Down 12.1% in 4 Weeks, Here's Why Prestige Brands (PBH) Looks Ripe for a Turnaround
- Prestige Brands (PBH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 08/29/2022
|
Prestige Brands (PBH) Moves to Buy: Rationale Behind the Upgrade
- Prestige Brands (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 08/23/2022
|
PBH vs. VZIO: Which Stock Should Value Investors Buy Now?
- PBH vs. VZIO: Which Stock Is the Better Value Option?
- 08/23/2022
|
Prestige Consumer Healthcare Inc.'s (PBH) CEO Ron Lombardi on Q1 2023 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q1 2023 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - Chairman, President and CEO Christine Sacco - Chief Financial Officer Conference Call Participants Chris Neamonitis - Jefferies Jon Andersen - William Blair Mitch Pinheiro - Sturdivant Erica Eiler - Oppenheimer Linda Bolton Weiser - D.A. Davidson Operator Good morning.
- 08/07/2022
|
Premium Brands Holdings Corporation (PRBZF) CEO George Paleologou on Q2 2022 Results - Earnings Call Transcript
- Premium Brands Holdings Corporation (OTCPK:PRBZF) Q2 2022 Earnings Conference Call August 5, 2022 1:30 PM ET Company Participants George Paleologou - President & Chief Executive Officer Will Kalutycz - Chief Financial Officer Conference Call Participants Derek Lessard - TD Securities Martin Landry - Stifel GMP George Doumet - Scotia Capital Stephen MacLeod - BMO Capital Markets John Zamparo - CIBC Vishal Shreedhar - National Bank Sabahat Khan - RBC Capital Operator Good afternoon, ladies and gentlemen, and welcome to the Premium Brands Holdings Corporation Second Quarter 2022 Earnings Conference Call. [Operator Instructions].
- 08/07/2022
|
Prestige Brands (PBH) Beats Q1 Earnings and Revenue Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 5.83% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2022
|
Prestige Consumer (PBH) Queued for Q1 Earnings: Things to Note
- Prestige Consumer's (PBH) first-quarter fiscal 2023 performance will likely reflect the impacts of escalated inflationary environment and supply-chain issues.
- 08/01/2022
|
Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High
- Prestige Consumer (PBH) is benefiting from its solid brand-building efforts and growing e-commerce business.
- 06/14/2022
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2022 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q4 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Phil Terpolilli - VP, IR Ron Lombardi - Chairman, President and CEO Christine Sacco - CFO Conference Call Participants Rupesh Parikh - Oppenheimer Stephanie Wissink - Jefferies Jon Anderson - William Blair Linda Bolton Weiser - D.A. Davidson Anthony Lebiedzinski - Sidoti Operator Good day ladies and gentlemen, thank you for standing by.
- 05/06/2022
|
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
- Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.
- 05/06/2022
|
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids
- Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.
- 04/12/2022
|
Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce
- Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.
- 03/14/2022
|
What Makes Prestige Brands (PBH) a New Buy Stock
- Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/04/2022
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2022 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2022 Results - Earnings Call Transcript
- 02/03/2022
|
Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/03/2022
|
Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings
- Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.
- 02/01/2022
|
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
- Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/27/2022
|
Should Value Investors Consider Prestige (PBH) Stock Now?
- Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.
- 12/21/2021
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2022 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2022 Results - Earnings Call Transcript
- 11/06/2021
|
Prestige Consumer (PBH) Tops Q2 Earnings & Revenue Estimates
- Prestige Consumer's (PBH) Q2 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.
- 11/05/2021
|
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
- Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.
- 11/01/2021
|
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results
- TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday, November 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
- 10/06/2021
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- LCUT vs. PBH: Which Stock Is the Better Value Option?
- 09/27/2021
|
Prestige Consumer Healthcare (PBH) Sees Hammer Chart Pattern: Time to Buy?
- Prestige Consumer Healthcare (PBH) has been struggling lately, but the selling pressure may be coming to an end soon.
- 09/15/2021
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- LCUT vs. PBH: Which Stock Is the Better Value Option?
- 09/11/2021
|
Prestige Consumer (PBH) Surges More Than 65% YTD: Here's Why
- Prestige Consumer (PBH) is consistently making multi-year e-commerce investments, which are yielding well. The company is focusing on the areas with significant prospects, such as healthcare.
- 09/03/2021
|
Earnings Estimates Rising for Prestige Brands (PBH): Will It Gain?
- Prestige Brands (PBH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 08/31/2021
|
Top Ranked Momentum Stocks to Buy for August 31st
- MOV, AAWW, PBH, and FCBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 31, 2021.
- 08/31/2021
|
Consumer Spending, Personal Income Continue to Rise: 5 Picks
- The rise in consumer confidence in July proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks like RICK, ALTO, PRTY, LCUT and PBH.
- 08/31/2021
|
LCUT vs. PBH: Which Stock Is the Better Value Option?
- LCUT vs. PBH: Which Stock Is the Better Value Option?
- 08/09/2021
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2022 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q1 2022 Results - Earnings Call Transcript
- 08/07/2021
|
Prestige Consumer (PBH) Beats Q1 Earnings & Revenue Estimates
- Prestige Consumer's (PBH) Q1 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.
- 08/06/2021
|
Prestige Brands (PBH) Q1 Earnings and Revenues Top Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 32.56% and 15.17%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/05/2021
|
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
- TARRYTOWN, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2021.
- 08/05/2021
|
Prestige Consumer (PBH) Queued for Q1 Earnings: Things to Note
- Prestige Consumer's (PBH) first-quarter fiscal 2022 performance is likely to reflect gains from strong e-commerce and brand-building efforts.
- 08/03/2021
|
Prestige Consumer (PBH) Adds TheraTears to Its Eye Care Portfolio
- Prestige Consumer (PBH) expanded its eye care portfolio by acquiring TheraTears and four other brands across the VMS and Cough & Cold categories.
- 07/02/2021
|
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 2022 Earnings Results Date
- TARRYTOWN, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige“ or the “Company”) today announced that it has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. The closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on May 27, 2021, under which Prestige agreed to acquire the brands from specialty pharmaceutical company, Akorn Operating Company LLC (“Akorn”), for $230 million in cash. The acquisition of TheraTears will further enhance Prestige's leading eye care portfolio and generate additional long-term growth opportunities for the Company.
- 07/01/2021
|
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
- TARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC (“Akorn”) for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA of ~$20 million equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add annual Revenues, Earnings Per Share and Operating Cash Flow of approximately $60 million, $0.10 and $13 million, respectively.
- 05/27/2021
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2021 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2021 Results - Earnings Call Transcript
- 05/08/2021
|
Prestige Consumer (PBH) Q4 Earnings Meet Estimates, Revenues Top
- Prestige Consumer's (PBH) fourth-quarter fiscal 2021 results reflect lower earnings and sales year over year due to pandemic-led disruptions in certain brands and tough comparisons with the year-ago period.
- 05/07/2021
|
Factors to Know Ahead of Prestige Consumer (PBH) Q4 Earnings
- Lower consumption patterns across certain categories and tough year-over-year comparisons might have hurt Prestige Consumer's (PBH) fourth-quarter fiscal 2021 performance.
- 05/04/2021
|
Earnings Preview: Prestige Brands (PBH) Q4 Earnings Expected to Decline
- Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/29/2021
|
Consumer Confidence Soars to One-Year High in March: 5 Picks
- The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, VSTO, SPB, SWBI, MBUU.
- 03/31/2021
|
Consumer Confidence Hits One-Year High: 5 Solid Stocks to Buy
- The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, CENT, SPB, MCFT, MBUU.
- 03/29/2021
|
Top Stocks To Buy Today As Bond Yields Pop And Nasdaq Plummets
- In anticipation of the Fed's big announcement on interest rates and inflation, Q.ai's Artificial Intelligence has brought you today's top buys.
- 03/17/2021
|
Consumer Confidence Hits Three-Month High: 4 Stocks to Buy
- The rise in consumer confidence in February proves that people are showing faith in the economy, which makes it an ideal time to invest in consumer discretionary stocks like Central Garden Pet Company(CENT) and DICKS Sporting Goods (DKS).
- 02/24/2021
|
Moving Average Crossover Alert: Prestige Consumer Healthcare (PBH)
- Prestige Consumer Healthcare (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- 02/18/2021
|
Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes
- TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), has priced an upsized offering of $600 million in aggregate principal amount of 3.750% senior notes due 2031 (the “notes”) in a private offering. The sale of the notes is expected to be completed on or about March 1, 2021, subject to customary closing conditions. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries.
- 02/10/2021
|
Prestige Consumer Healthcare Inc. Announces Offering of $500 Million Senior Notes
- TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), intends to offer, subject to market and other conditions, up to $500 million in aggregate principal amount of new senior notes due 2031 (the “notes”) in a private offering. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries.
- 02/10/2021
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2021 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q3 2021 Results - Earnings Call Transcript
- 02/04/2021
|
Prestige Consumer (PBH) Q3 Earnings & Revenues Top Estimates
- Prestige Consumer's (PBH) third-quarter fiscal 2021 results reflect stable consumption for most brands and solid e-commerce growth. However, some brands witness lower consumption amid the pandemic.
- 02/04/2021
|
Prestige Brands (PBH) Q3 Earnings and Revenues Beat Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 5.19% and 2.90%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/04/2021
|
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Third Quarter Results
- TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2020.
- 02/04/2021
|
Prestige Consumer (PBH) to Post Q3 Earnings: Things to Know
- Prestige Consumer's (PBH) third-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories as well as higher advertising and marketing costs.
- 02/02/2021
|
Why STAAR Surgical and Prestige Consumer Healthcare Stocks Jumped Today
- Both companies are set to join new market indexes.
- 01/26/2021
|
Staar Surgical Set to Join S&P MidCap 400; Prestige Consumer Healthcare & Bridge Bancorp to Join S&P SmallCap 600
- NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Staar Surgical Co. (NASD: STAA) will replace Prestige Consumer Healthcare Inc. (NYSE: PBH) in the S&P MidCap 400, and Prestige Consumer Healthcare will...
- 01/25/2021
|
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnings Results
- TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
- 01/08/2021
|
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript
- Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript
- 11/06/2020
|
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results
- TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2020.
- 11/05/2020
|
SENTA Partners Completes 3rd Affiliation in Two Months Through Partnership With Valdosta ENT
- Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with ENT & Allergy Associate
- 10/20/2020
|
SENTA Expands Presence to 50 Providers and 23 Clinical Locations in Metro Atlanta Through Affiliation With Atlanta Allergy & Asthma
- Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with Atlanta Allergy & Asthm
- 09/30/2020
|
Did Hedge Funds Make The Right Call On Prestige Consumer Healthcare Inc. (PBH) ?
- We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
- 08/11/2020
|
Prestige Brands (PBH) Q1 Earnings and Revenues Beat Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 22.86% and 3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/06/2020
|
Prestige Consumer Healthcare's (NYSE:PBH) Shareholders Are Down 24% On Their Shares
- As an investor its worth striving to ensure your overall portfolio beats the market average. But the risk of stock...
- 08/06/2020
|
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 First Quarter Results
- * Revenue was $229.4 Million in First Quarter Fiscal 2021, Down 0.6% from Prior Year Q1 Excluding Unfavorable Foreign Currency * Diluted EPS of $0.86 in First Quarter Fiscal 2021, up 32% from Prior Year Q1 * Generated Cash from Operations of $75.2 Million and Non-GAAP Free Cash Flow of $72.6 Million in First Quarter Fiscal 2021TARRYTOWN, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2020.“We are pleased with our results for the first quarter which included solid earnings and record free cash flow. We also delivered a stable revenue performance, despite the pandemic, led by the fast-growing eCommerce channel where our investments over the last several years are providing accelerating benefits. Even in an environment where people’s lifestyles, activities and routines have been disrupted by the COVID-19 pandemic, consumers continue to turn to our portfolio of trusted brands,” said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.“Our solid start to the year is a testament to our Company’s strong brand positioning and strategic ability to navigate this unique and uncertain business environment. We are protecting the health & safety of our workforce, partners and community all while continuing to execute our time-tested brand-building strategy and maintaining our leading financial profile,” Mr. Lombardi concluded.First Fiscal Quarter Ended June 30, 2020Reported revenues in the first quarter of fiscal 2021 decreased 1.2% to $229.4 million, compared to $232.2 million in the first quarter of fiscal 2020. Revenues decreased 0.6% excluding the impact of foreign currency. The revenue performance for the quarter was driven by stable consumption across the majority of the Company’s portfolio and a benefit associated with higher retailer order patterns to refill customer’s supply chains. This was partially offset by reduced consumption for certain brands where the category has been impacted by the COVID-19 virus.Reported net income for the first quarter of fiscal 2021 totaled $43.7 million versus the prior year comparable quarter’s net income of $33.9 million. Diluted earnings per share of $0.86 for the first quarter of fiscal 2021 compared to $0.65 in the prior year comparable period.Free Cash Flow and Balance SheetThe Company's net cash provided by operating activities for first quarter fiscal 2021 was $75.2 million compared to $52.8 million during the prior year. Non-GAAP free cash flow in first quarter fiscal 2021 was $72.6 million compared to $50.8 million in the prior year. The Company’s business experienced continued strong cash conversion from its leading financial profile.The Company's net debt position as of June 30, 2020 was approximately $1.6 billion and at the end of the first quarter fiscal 2021 the Company's covenant-defined leverage ratio was 4.4x. During the quarter the Company lowered debt outstanding by $111 million as it continued to maintain focus on debt reduction.Segment ReviewNorth American OTC Healthcare: Segment revenues totaled $210.7 million for the first quarter of fiscal 2021, compared to the prior year comparable quarter's revenues of $210.8 million. The first quarter fiscal 2021 revenue performance was impacted by a reduction in consumption for certain brands where the category consumption levels have been impacted by the COVID-19 virus, largely offset by a benefit associated with higher retailer order patterns to refill customer’s supply chains.International OTC Healthcare: Segment fiscal first quarter 2021 revenues totaled $18.7 million, compared to $21.4 million reported in the prior year comparable period. Revenues versus the prior year were impacted by reduced consumption for certain brands impacted by the COVID-19 virus as well as unfavorable foreign currency of approximately $1 million, partially offset by a benefit associated with higher retailer order patterns to refill customer’s supply chains.Commentary and Outlook for Fiscal 2021Ron Lombardi, Chief Executive Officer, stated, “We delivered a strong start to the fiscal year, which included first quarter revenues better than anticipated owing to strength from our ongoing brand-building efforts and significant growth in eCommerce channel sales stemming from our long-term investments. The first quarter also experienced strong earnings and free cash flow that were driven by strong EBITDA and the benefit of our disciplined capital allocation strategy over the last year. We reduced debt by $111 million in the first quarter, which resulted in 4.4x leverage, close to the mid-point of our targeted long-term leverage range.”“As we look forward in the near-term we anticipate revenues in Q2 of $225 million or more. This outlook is driven by continued changes in consumer behaviors and disruptions in certain channels stemming from the COVID-19 virus, which has affected demand in certain categories that we compete in. Despite these challenges, we remain focused on brand-building and maintaining or growing market share across our portfolio of core brands, many of which have unique opportunities for investment in the current environment. Meanwhile, we anticipate Q2 EPS of $0.70 or more, an increase from the prior year, thanks to our disciplined cost management, leading financial profile and benefits of our capital allocation strategy” he continued.“We continue to refrain from offering full-year guidance given the uncertainties ahead, but we are confident in our sound Company and business strategy that positions us well to withstand these challenges as evidenced in our results announced today. Our leading brand-building efforts, financial profile and disciplined capital allocation approach will enable us to focus on long-term top- and bottom-line growth prospects that position us for continued success,” he concluded.Fiscal First Quarter 2021 Conference Call, Accompanying Slide Presentation and Replay The Company will host a conference call to review its first quarter results today, August 6, 2020 at 8:30 a.m. ET. The toll-free dial-in numbers are 844-233-9440 for the U.S. & Canada and 574-990-1016 internationally. The conference ID number is 4482198. The Company provides a live Internet webcast, a slide presentation to accompany the call, as well as an archived replay, all of which can be accessed from the Investor Relations page of the Company's website at www.prestigeconsumerhealthcare.com. The slide presentation can be accessed from the Investor Relations page of the website by clicking on Webcasts and Presentations.Telephonic replays will be available for approximately one week following the completion of the call and can be accessed at 855-859-2056 within North America and at 404-537-3406 from outside North America. The conference ID is 4482198.Non-GAAP and Other Financial Information In addition to financial results reported in accordance with generally accepted accounting principles (GAAP), we have provided certain non-GAAP financial information in this release to aid investors in understanding the Company's performance. Each non-GAAP financial measure is defined and reconciled to its most closely related GAAP financial measure in the “About Non-GAAP Financial Measures” section at the end of this earnings release.Note Regarding Forward-Looking Statements This news release contains "forward-looking statements" within the meaning of the federal securities laws that are intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "target," "guidance," "strategy," "outlook," "plans," "projection," "focus," "may," "will," "would," "expect," "anticipate," "believe”, "positions," "enables," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the Company's expectations regarding its ability to withstand challenges from the COVID-19 outbreak including its ability to protect the health and safety of employees, partners and community and its ability to adapt to a changing business environment, future operating results including revenues, the Company’s ability to execute on its brand-building strategy, maintain a leading financial profile, and maintain or grow market share, and the Company’s ability to position itself for continued success. These statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those expected as a result of a variety of factors, including the impact of the COVID-19 pandemic and business and economic conditions, the impact of the Company’s advertising and promotional and new product development initiatives, customer inventory management initiatives, fluctuating foreign exchange rates, competitive pressures, and the ability of the Company’s third party manufacturers and logistics providers and suppliers to meet demand for its products and to reduce costs. A discussion of other factors that could cause results to vary is included in the Company's Annual Report on Form 10-K for the year ended March 31, 2020 and other periodic reports filed with the Securities and Exchange Commission.About Prestige Consumer Healthcare Inc. The Company markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets.
- 08/06/2020
|
Prestige Consumer Healthcare (PBH) Set to Announce Quarterly Earnings on Thursday
- Prestige Consumer Healthcare (NYSE:PBH) is scheduled to be announcing its earnings results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of $0.70 per share for the quarter. Prestige Consumer Healthcare has set its Q1 2021 Pre-Market guidance at 0.70 EPS and its Q1 guidance at $0.70 or more […]
- 08/04/2020
|
Nisa Investment Advisors LLC Grows Stock Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Nisa Investment Advisors LLC boosted its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 57.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 38,983 shares of the company’s stock after acquiring an additional 14,173 shares during the quarter. Nisa Investment […]
- 08/03/2020
|
Registration - Sidoti's 2020 Fall Virtual Investor Conference is Open Now.
- Our Biannual Investor Conference has become a leading forum for small-cap companies to interface with investors specifically interested in the small-cap equities.
- 07/31/2020
|
Prestige Brands (PBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/30/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $97.00
- Prestige Consumer Healthcare (NYSE:PBH) had its price objective raised by TD Securities from $90.00 to $97.00 in a report issued on Friday morning, Stock Target Advisor reports. They currently have a hold rating on the stock. A number of other research analysts also recently commented on PBH. BMO Capital Markets upped their price objective on […]
- 07/27/2020
|
Electrolyte Mixes Market with Impact of COVID-19 Highlights (2019-2023)| Health Benefits Of Electrolyte Mixes to boost the Market Growth | Technavio
- The Global Electrolyte Mixes Market will grow by $ 415.93 mn during 2019-2023
- 07/20/2020
|
Trust Co. of Vermont Has $805,000 Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Trust Co. of Vermont lowered its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 12.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 21,437 shares of the company’s stock after selling 3,017 shares during the quarter. Trust Co. of Vermont’s holdings in […]
- 07/19/2020
|
Prestige Consumer Healthcare (NYSE:PBH) vs. Zai Lab (NYSE:ZLAB) Critical Survey
- Prestige Consumer Healthcare (NYSE:PBH) and Zai Lab (NASDAQ:ZLAB) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Analyst Ratings This is a breakdown of current ratings and target prices for Prestige […]
- 07/14/2020
|
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results
- TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6, 2020 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4482198. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 4482198.About Prestige Consumer Healthcare Inc.Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.Investor Relations ContactPhil Terpolilli, CFA, 914-524-6819irinquiries@prestigebrands.com
- 07/13/2020
|
Voloridge Investment Management LLC Cuts Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Voloridge Investment Management LLC decreased its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 54.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,863 shares of the company’s stock after selling 6,880 shares during the period. Voloridge Investment Management LLC’s holdings in Prestige Consumer […]
- 07/04/2020
|
OHR Pharmaceutical (NASDAQ:OHRP) and Prestige Consumer Healthcare (NASDAQ:PBH) Critical Analysis
- Prestige Consumer Healthcare (NYSE:PBH) and OHR Pharmaceutical (NASDAQ:OHRP) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 10.7% of OHR Pharmaceutical shares are held by institutional […]
- 07/04/2020
|
Ipsen : Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-Small Cell Lung Cancer and Metastatic Castration-Resistant Prostate Cancer | MarketScreener
|
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-Small Cell Lung Cancer and Metastatic Castration-Resistant Prostate Cancer
- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
- 07/02/2020
|
GSK trionfa ai Consumer Healthcare Creative Awards di Teads | Engage
- Teads annuncia i vincitori dei Consumer Healthcare Creative Awards, i premi che celebrano l’impegno creativo per strategie digitali mobile nel settore CHC
- 06/30/2020
|
Why Prestige Consumer Healthcare Is Struggling In The New COVID-19 E-Commerce Centric World
- Prestige Consumer Healthcare is non-value accretive roll-up of OTC Healthcare consumer products. In the new COVID-19 env't, we believe it is a net-loser due to
- 06/30/2020
|
IPSEN S A/S (OTCMKTS:IPSEY) Shares Pass Above 200 Day Moving Average of $18.44
- Shares of IPSEN S A/S (OTCMKTS:IPSEY) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $18.44 and traded as high as $20.67. IPSEN S A/S shares last traded at $20.67, with a volume of 356 shares traded. IPSEY has been the subject of a number […]
- 06/26/2020
|
Two Sigma Investments LP Takes Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Two Sigma Investments LP purchased a new stake in Prestige Consumer Healthcare Inc (NYSE:PBH) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 20,776 shares of the company’s stock, valued at approximately $762,000. Other institutional investors also recently added to or […]
- 06/25/2020
|
Prestige Consumer Healthcare Inc. (PBH): Hedge Funds Are Coming Back
- At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]
- 06/24/2020
|
Alliancebernstein L.P. Sells 4,970 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Alliancebernstein L.P. reduced its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 3.8% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 126,775 shares of the company’s stock after selling 4,970 shares during the quarter. Alliancebernstein L.P. owned 0.25% of Prestige Consumer Healthcare worth […]
- 06/24/2020
|
Teads comunica i finalisti dei Consumer Healthcare Creative Awards | Engage
- Annunciati i brand ammessi alla sfida finale dell'evento Teads che fa parte del Mese della Creatività. La premiazione il 25 giugno
- 06/23/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Stock Holdings Increased by Balyasny Asset Management LLC
- Balyasny Asset Management LLC lifted its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 19.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,122 shares of the company’s stock after purchasing an additional 3,975 shares during the quarter. Balyasny Asset Management LLC’s […]
- 06/23/2020
|
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Grows Stake in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 33.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,818 shares of the company’s stock after purchasing an additional 2,958 shares […]
- 06/21/2020
|
Prestige Consumer Healthcare (PBH) Investor Presentation - Slideshow
- The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with this event.
- 06/19/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Bought by Federated Hermes Inc.
- Federated Hermes Inc. grew its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 30.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,767 shares of the company’s stock after acquiring an additional 4,169 shares during the […]
- 06/18/2020
|
Assessment of COVID-19's Effect on Throat Pastilles and Cough Drops Market 2020-2024 | Emergence of Innovative Products to Augment Growth | Technavio
- The Global Throat Pastilles and Cough Drops Market will grow by USD 1.03 bn during 2020-2024
- 06/18/2020
|
3 Dow Jones Companies to Buy When Profit-Taking Kicks In
- Are you wondering which Dow Jones companies to buy right now? Let's take a closer look at three top names that could belong in a long-term portfolio.
- 06/17/2020
|
Uriach va facturar un 16% més el 2019 i busca compres a Europa tot i la crisi
- La farmacèutica arriba als 228 milions d'euros de facturació i no es veu afectada pel covid-19
- 06/17/2020
|
GlaxoSmithKline : GSK Consumer Healthcare teams up with Paula Abdul for the launch of Voltaren Arthritis Pain Gel | MarketScreener
|
New Zealand advert featuring nude 'porn actors' praised for promoting internet safety
- Video part of campaign to help children navigate ‘choppy waters’ of online world
- 06/15/2020
|
Nude 'porn stars' go viral in NZ government TV ad on internet safety
- An unusual New Zealand government advert featuring naked 'porn stars' has racked up millions of views after becoming an online hit around the world. The advert, part of a series that promotes internet safety, shows a couple known as Nude Sue and Derek turn up at a mother’s front door and announce: “Hiya… your son’s been watching us online.”
- 06/15/2020
|
Marc Princen appointed new Global CEO for Mundipharma
- CAMBRIDGE, England — FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated companies as the Global…
- 06/15/2020
|
Marc Princen appointed new Global CEO for Mundipharma
- FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently associated com
- 06/15/2020
|
Advert shows naked pornstars telling mum her son has been looking for porn online in bizarre safety campaign
- A BIZARRE advert has caused a stir after it showed two naked pornstars telling a mother that her son had been searching for porn online, in a bid to get parents to open up about sex. The advert is…
- 06/12/2020
|
Prestige Brands (PBH) Up 3.5% Since Last Earnings Report: Can It Continue?
- Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/06/2020
|
Edited Transcript of PBH earnings conference call or presentation 7-May-20 12:30pm GMT
- Q4 2020 Prestige Consumer Healthcare Inc Earnings Call
- 06/04/2020
|
Teads, al via gli eventi online del Mese della Creatività | Engage
- Teads inaugura oggi "Il Mese della Creatività", eventi online per raccontare la creatività nell’attuale situazione dell’industria pubblicitaria
- 06/04/2020
|
Women's Intimate Care Products Market 2020-2024 | Premiumization of Products to Boost Growth | Technavio
- The Global Women's Intimate Care Products Market will grow by USD 299.26 mn during 2020-2024
- 06/03/2020
|
IPSEN: Description of the Regulatory Framework of the Share Repurchase Program Proposed by the Board of Directors to Be Approved at the Combined Shareholders’ Meeting on 29 May 2020 (17th resolution)
- Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at the Combined Shareholder
- 05/29/2020
|
GSK Stock Up 1.25%, GlaxoSmithKline to Make 1B Doses of Coronavirus Vaccine Booster
- GlaxoSmithKline said it is planning to produce 1 billion doses of a vaccine adjuvant next year, meanwhile, GSK stock is up.
- 05/28/2020
|
What We Learned From Sold Positions at Polen Capital
- Mega-merger, diworsification and digital disruption Continue reading...
- 05/26/2020
|
What We Learned From Sold Positions at Polen Capital
|
Edited Transcript of PBH earnings conference call or presentation 7-May-20 12:30pm GMT
- Q4 2020 Prestige Consumer Healthcare Inc Earnings Call
- 05/25/2020
|
Ipsen: New Surveys Show Over 80% of Patients with Spasticity and Cervical Dystonia Treated with Botulinum Toxin-A Experience Debilitating Symptom Recurrence
- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presents the results of two patient surveys. The surveys involved over 400 respondents from f
- 05/23/2020
|
Pfizer: A Post Spinoff Dividend Growth Opportunity (NYSE:PFE)
- Pfizer, a former dividend aristocrat, has shown slow growth of key financial metrics over the last decade partly due to problems integrating acquisitions and re
- 05/21/2020
|
Moving Average Crossover Alert: Prestige Consumer Healthcare
- Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- 05/20/2020
|
Ovulation Test Market Size 2020: Worldwide Overview, Future Opportunities, Growth, Trends, Top Players Analysis and Forecast up to 2026
- May 15, 2020 (The Expresswire) --
Global “Ovulation Test Market ” analysis 2020 covers the entire supply chain, focusing on supply, demand, trade and prices...
- 05/15/2020
|
Why Johnson & Johnson Looks Undervalued At $145
- Johnson & Johnson’s stock has outperformed the broader markets as well as some of its peers over the last few weeks. While J&J stock grew 32% since the recent lows of March 23, the S&P 500 gained 26%. Looking at other pharmaceutical giants, Roche gained 27%, Novartis is up 20%, Pfizer 30%...
- 05/15/2020
|
Unilever : GSK Announced The Completion Of Merger With Hindustan Unilever Limited For Various Healthcare Products In India | MarketScreener
|
Prestige Consumer Healthcare Inc (PBH) CEO Ronald M. Lombardi Sold $–.— million of Shares
|
Analysts Have Made A Financial Statement On Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Annual Report
- Prestige Consumer Healthcare Inc. (NYSE:PBH) last week reported its latest annual results, which makes it a good time...
- 05/11/2020
|
COVID-19 Impact and Recovery Analysis | Global Osteoarthritis Therapeutics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Anika Therapeutics Inc. | Technavio
- The osteoarthritis therapeutics market size has the potential to grow by USD 2.99 billion during 2020-2024
- 05/08/2020
|
Prestige Consumer Healthcare Inc (PBH) Q4 2020 Earnings Call Transcript
- On the call with me today are Ron Lombardi, our Chairman, President and CEO; and Chris Sacco, our CFO. On today's call, we'll begin with some topical remarks, given the current crisis, review the results of the fourth quarter and fiscal year 2020, discuss our approach and initial thoughts on fiscal 2021 and then take questions from analysts. There's a slide presentation which accompanies today's call, can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the Investors link and then on today's webcast and presentation.
- 05/07/2020
|
Prestige Consumer (PBH) Q4 Earnings & Revenues Top Estimates
- Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.
- 05/07/2020
|
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
- Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2020
|
Prestige Consumer Sees Q1 EPS $0.70+, Sales $220M+
|
Prestige Consumer Q4 EPS $0.820 Beats $0.740 Estimate, Sales $251.235M Beat $239.840M Estimate
|
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
- Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1.
- 05/07/2020
|
Karuna Therapeutics Reports First Quarter 2020 Financial Results and Provides General Business Update
- Karuna Therapeutics, Inc. (Nasdaq: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the pote
- 05/07/2020
|
Analysis on New Product Launches in Covid-19 Related Markets-Global Allergy Rhinitis Drugs Market 2020-2024 | Evolving Opportunities with Alcon Inc. and ALK-Abello AS | Technavio
- The allergy rhinitis drugs market size has the potential to grow by USD 2.4 billion during 2020-2024
- 05/05/2020
|
Ipsen enters into an option agreement with IRICoR and Université de Montréal for a discovery-stage oncology program
- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercializati
- 05/04/2020
|
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
- Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
- Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2020
|
Zacks: Analysts Expect Prestige Consumer Healthcare Inc (NYSE:PBH) to Announce $0.74 Earnings Per Share
- Wall Street brokerages expect Prestige Consumer Healthcare Inc (NYSE:PBH) to announce $0.74 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The lowest EPS estimate is $0.71 and the highest is $0.81. Prestige Consumer Healthcare posted earnings of $0.72 per share […]
- 04/30/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Stake Lifted by BBVA USA Bancshares Inc.
- BBVA USA Bancshares Inc. lifted its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 64.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 16,329 shares of the company’s stock after purchasing an additional 6,380 shares during the quarter. BBVA USA Bancshares Inc.’s holdings […]
- 04/30/2020
|
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
|
Helen of Troy (HELE) Stock Up as Q4 Earnings & Sales Rise Y/Y
- Helen of Troy's (HELE) Q4 results benefit from increased demand for certain products along with double-digit growth in all three business segments
- 04/29/2020
|
PFIZER Reports First-Quarter 2020 Results | STL.News
- PFIZER Reports First-Quarter 2020 Results | STL.News | Read business news and more at STL.News. Please share.
- 04/28/2020
|
Sanofi Q1 2020 Earnings Call Key Takeaways
- We highlight main points from the SNY Q1 conference call and summarize key takeaways for investors. Q1 results were strong overall, but taking away COVID-19 add
- 04/27/2020
|
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results
- TARRYTOWN, N.Y., April 27, 2020 -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 fourth quarter and year-end earnings release.
- 04/27/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Sold by Ladenburg Thalmann Financial Services Inc.
- Ladenburg Thalmann Financial Services Inc. lessened its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 24.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 958 shares of the company’s stock after selling 305 shares during the quarter. Ladenburg Thalmann Financial […]
- 04/25/2020
|
Is Prestige Consumer Healthcare Inc. (NYSE:PBH) Trading At A 40% Discount?
- Does the April share price for Prestige Consumer Healthcare Inc. (NYSE:PBH) reflect what it's really worth? Today, we...
- 04/20/2020
|
How Damaging Has Coronavirus Been to Wolverine (WWW) Q1 Earnings?
- Wolverine (WWW) closes retail outlets amid coronavirus crisis. Loss of sales from such stores is likely to show on first-quarter 2020 results.
- 04/20/2020
|
How Damaging Has Coronavirus Been to Wolverine (WWW) Q1 Earnings?
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Sees Large Decline in Short Interest
- Prestige Consumer Healthcare Inc (NYSE:PBH) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 4,710,000 shares, a decrease of 39.1% from the March 15th total of 7,734,200 shares. Based on an average daily volume of 586,000 shares, the short-interest ratio […]
- 04/18/2020
|
Snap-on (SNA) to Report Q1 Earnings: What's in the Offing?
- Snap-on's (SNA) first-quarter 2020 results are likely to reflect adverse impacts of foreign currency translation. Nevertheless, benefits from robust business model and growth strategies bode well.
- 04/17/2020
|
Sanofi desarrolla un test de autodiagnóstico de Covid-19 para el móvil
- En colaboración con Luminostics prueba un kit que detecta el virus gracias a la óptica de la cámara y utilizando la luminiscencia
- 04/17/2020
|
Equities Analysts Set Expectations for Prestige Consumer Healthcare Inc's FY2021 Earnings (NYSE:PBH)
- Prestige Consumer Healthcare Inc (NYSE:PBH) – Investment analysts at Jefferies Financial Group upped their FY2021 earnings per share estimates for shares of Prestige Consumer Healthcare in a research report issued to clients and investors on Tuesday, April 14th. Jefferies Financial Group analyst S. Wissink now expects that the company will post earnings of $3.09 per […]
- 04/17/2020
|
Beyondspring (NASDAQ:BYSI) and Prestige Consumer Healthcare (NASDAQ:PBH) Critical Review
- Beyondspring (NASDAQ:BYSI) and Prestige Consumer Healthcare (NYSE:PBH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for Beyondspring and Prestige Consumer Healthcare, […]
- 04/17/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Lowered by TD Securities
- Prestige Consumer Healthcare (NYSE:PBH) was downgraded by equities researchers at TD Securities to a “hold” rating in a report issued on Tuesday, Stock Target Advisor reports. They currently have a $86.00 target price on the stock. TD Securities’ price objective indicates a potential upside of 129.58% from the company’s previous close. Several other equities analysts […]
- 04/16/2020
|
Johnson & Johnson Beats Q1 Estimates, Raises Dividend - Market Realist
- Johnson & Johnson stock rose 4.7% as of 12:30 PM ET today. Investors are optimistic about the company’s strong first-quarter results and a dividend hike.
- 04/14/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Stock Holdings Lifted by Geode Capital Management LLC
- Geode Capital Management LLC grew its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 4.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 716,469 shares of the company’s stock after buying an additional 30,709 shares during the quarter. Geode Capital Management LLC’s holdings in Prestige Consumer Healthcare were worth $29,016,000 at […]
- 04/12/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Acquired by AQR Capital Management LLC
- AQR Capital Management LLC lifted its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 67.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,923 shares of the company’s stock after acquiring an additional 4,817 shares during the period. AQR […]
- 04/11/2020
|
Cubist Systematic Strategies LLC Sells 36,379 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Cubist Systematic Strategies LLC lessened its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 71.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,502 shares of the company’s stock after selling 36,379 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in Prestige […]
- 04/09/2020
|
Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.
|
Is Prestige Brands Holdings, Inc. (PBH) A Good Stock To Buy?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/08/2020
|
Hedge Funds Have Never Been This Bullish On CommVault Systems, Inc. (CVLT)
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/07/2020
|
Hedge Funds Are Dumping BancFirst Corporation (BANF)
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/07/2020
|
Patterson-UTI Energy, Inc. (PTEN): Are Hedge Funds Right About This Stock?
- Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to […]
- 04/07/2020
|
Nuveen Asset Management LLC Sells 26,590 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Nuveen Asset Management LLC lowered its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 2.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,132,251 shares of the company’s stock after selling 26,590 shares during the period. Nuveen Asset Management LLC owned about 2.25% […]
- 04/07/2020
|
$240.47 Million in Sales Expected for Prestige Consumer Healthcare Inc (NYSE:PBH) This Quarter
- Equities research analysts expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will report sales of $240.47 million for the current quarter, Zacks reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The highest sales estimate is $249.30 million and the lowest is $235.20 million. Prestige Consumer Healthcare posted sales of $241.03 million in the […]
- 04/06/2020
|
Bank of New York Mellon Corp Buys 22,779 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Bank of New York Mellon Corp increased its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 688,934 shares of the company’s stock after purchasing an additional 22,779 shares during the quarter. Bank of New […]
- 04/04/2020
|
Critical Review: Sunesis Pharmaceuticals (NASDAQ:SNSS) vs. Prestige Consumer Healthcare (NASDAQ:PBH)
- Sunesis Pharmaceuticals (NASDAQ:SNSS) and Prestige Consumer Healthcare (NYSE:PBH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Analyst Ratings This is a summary of current ratings and price targets for Sunesis […]
- 04/04/2020
|
Zacks: Brokerages Anticipate Prestige Consumer Healthcare Inc (NYSE:PBH) Will Announce Earnings of $0.74 Per Share
- Analysts expect Prestige Consumer Healthcare Inc (NYSE:PBH) to post $0.74 earnings per share for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Prestige Consumer Healthcare’s earnings, with the highest EPS estimate coming in at $0.81 and the lowest estimate coming in at $0.71. Prestige Consumer Healthcare posted earnings per share of […]
- 04/04/2020
|
Short Interest in Prestige Consumer Healthcare Inc (NYSE:PBH) Increases By 5.1%
- Prestige Consumer Healthcare Inc (NYSE:PBH) was the target of a significant growth in short interest in the month of March. As of March 13th, there was short interest totalling 7,734,200 shares, a growth of 5.1% from the February 27th total of 7,360,000 shares. Approximately 15.5% of the company’s shares are sold short. Based on an […]
- 04/03/2020
|
Why WD-40's Recent Credit Revolver Max-Out Exposes Greater Risk This Cycle Vs. The Past: 55%-60% Downside Risk
- WD-40 and the two sell-side analysts covering it tout WD-40 as a recession resistant investment, a claim we believe doesn't stand up to rigorous analysis. Last
- 04/02/2020
|
Bank of America Corp DE Cuts Stake in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Bank of America Corp DE cut its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 432,700 shares of the company’s stock after selling 13,251 shares during the quarter. Bank of America Corp […]
- 04/02/2020
|
Granddaughter praises carers who let her nana die 'with respect and dignity'
- Irene Healey, 95, died last week and the family said her care team were 'amazing people'
- 03/31/2020
|
CA Family Wealth LLC Purchases Shares of 5,144 Prestige Consumer Healthcare Inc (NYSE:PBH)
- CA Family Wealth LLC bought a new position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 5,144 shares of the company’s stock, valued at approximately $208,000. Several other hedge funds and other institutional investors have also […]
- 03/31/2020
|
Pfizer Inc (NYSE: PFE) Q4 2019 Earnings Call Transcript | AlphaStreet
- Good day, everyone, and welcome to Pfizer's Fourth Quarter 2019 Earnings Conference Call. Today's call is being recorded.
- 03/30/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Lifted to "Buy" at Jefferies Financial Group
- Jefferies Financial Group upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a hold rating to a buy rating in a report published on Thursday, Benzinga reports. They currently have $43.00 target price on the stock. Several other research analysts have also weighed in on the company. Oppenheimer started coverage on Prestige Consumer Healthcare in a […]
- 03/30/2020
|
Amalgamated Bank Boosts Stock Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Amalgamated Bank lifted its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 8.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,700 shares of the company’s stock after acquiring an additional 670 shares during the quarter. Amalgamated Bank’s holdings in Prestige Consumer […]
- 03/29/2020
|
Blueshift Asset Management LLC Takes Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Blueshift Asset Management LLC acquired a new stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 5,990 shares of the company’s stock, valued at approximately $243,000. Several other hedge funds and other institutional investors also recently made changes to their positions in the company. […]
- 03/28/2020
|
Alberta Investment Management Corp Purchases 11,600 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Alberta Investment Management Corp lifted its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 19.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 71,000 shares of the company’s stock after buying an additional 11,600 shares during the quarter. Alberta Investment Management Corp […]
- 03/27/2020
|
Analysts Issue Forecasts for Prestige Consumer Healthcare Inc's FY2020 Earnings (NYSE:PBH)
- Prestige Consumer Healthcare Inc (NYSE:PBH) – Research analysts at Oppenheimer issued their FY2020 earnings per share estimates for Prestige Consumer Healthcare in a report released on Monday, March 23rd. Oppenheimer analyst R. Parikh expects that the company will post earnings of $2.87 per share for the year. Oppenheimer has a “Market Perform” rating on the […]
- 03/27/2020
|
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 45% Undervalued
- In this article we are going to estimate the intrinsic value of Prestige Consumer Healthcare Inc. (NYSE:PBH) by taking...
- 03/26/2020
|
's Top Upgrades, Downgrades For March 26, 2020
- Upgrades
B. Riley FBR changed the rating for American Finance Trust Inc (NASDAQ: AFIN) from Neutral to Buy. American Finance Trust earned $0.24 in the fourth...
- 03/26/2020
|
Jefferies Upgrades Prestige Consumer to Buy, Announces $43 Price Target
|
Envestnet Asset Management Inc. Has $843,000 Stake in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Envestnet Asset Management Inc. increased its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 8.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,811 shares of the company’s stock after buying an additional 1,547 shares during the period. Envestnet […]
- 03/25/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Now Covered by Oppenheimer
- Investment analysts at Oppenheimer assumed coverage on shares of Prestige Consumer Healthcare (NYSE:PBH) in a research report issued on Monday, Marketbeat.com reports. The firm set a “market perform” rating on the stock. Other equities analysts have also issued reports about the company. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” […]
- 03/25/2020
|
Algert Global LLC Purchases 14,915 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Algert Global LLC grew its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 106.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,929 shares of the company’s stock after buying an additional 14,915 shares during the quarter. Algert Global LLC […]
- 03/25/2020
|
Oppenheimer initiates Prestige Brands with a Perform on more balanced outlook PBH
- Oppenheimer initiates Prestige Brands with a Perform on more balanced outlook Oppenheimer PBH
- 03/24/2020
|
Oppenheimer Initiates Coverage On Prestige Consumer with Perform Rating
|
Oppenheimer Initiates a Hold Rating on Prestige Brand Holdings (PBH)
- Prestige Brand Holdings (PBH – Research Report) received a Hold rating from Oppenheimer analyst Rupesh Parikh today. The company’s shares
- 03/23/2020
|
Volatility 101: Should Prestige Consumer Healthcare (NYSE:PBH) Shares Have Dropped 46%?
- For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
- 03/23/2020
|
Panagora Asset Management Inc. Sells 8,015 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Panagora Asset Management Inc. reduced its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 64.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,394 shares of the company’s stock after selling 8,015 shares during the quarter. Panagora Asset Management Inc.’s holdings in Prestige Consumer […]
- 03/23/2020
|
Prestige Brands initiated with a Perform at Oppenheimer PBH
- Prestige Brands initiated with a Perform at Oppenheimer Oppenheimer PBH
- 03/23/2020
|
Great West Life Assurance Co. Can Makes New $980,000 Investment in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Great West Life Assurance Co. Can purchased a new position in Prestige Consumer Healthcare Inc (NYSE:PBH) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 24,367 shares of the company’s stock, valued at approximately $980,000. Several other hedge funds and other […]
- 03/23/2020
|
Citigroup Inc. Sells 47,020 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Citigroup Inc. lessened its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 79.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,202 shares of the company’s stock after selling 47,020 shares during the period. Citigroup Inc.’s holdings in Prestige […]
- 03/22/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Raised to "Sell" at ValuEngine
- ValuEngine upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a strong sell rating to a sell rating in a report published on Wednesday, ValuEngine reports. Other equities research analysts also recently issued research reports about the company. DA Davidson reaffirmed a neutral rating on shares of Prestige Consumer Healthcare in a report on Friday, February […]
- 03/22/2020
|
AlphaCrest Capital Management LLC Trims Stock Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
- AlphaCrest Capital Management LLC trimmed its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 6.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,214 shares of the company’s stock after selling 683 shares during the quarter. AlphaCrest Capital Management LLC’s holdings in […]
- 03/21/2020
|
's Top Upgrades, Downgrades For March 19, 2020
- Upgrades
For Powell Industries Inc (NASDAQ: POWL), Sidoti & Co. upgraded the stock from Neutral to Buy. Powell Industries earned $0.24 in the first quarter,...
- 03/19/2020
|
Prestige Brands upgraded to Buy from Neutral at DA Davidson PBH
- Prestige Brands upgraded to Buy from Neutral at DA Davidson PBH
- 03/19/2020
|
DA Davidson Upgrades Prestige Consumer to Buy
|
Prestige Brands upgraded to Buy from Neutral at DA Davidson PBH
- Prestige Brands upgraded to Buy from Neutral at DA Davidson DA Davidson PBH
- 03/19/2020
|
Stocks To Watch: Prestige Brands Sees Relative Strength Rating Jump To 83
|
Bank of Montreal Can Boosts Stake in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Bank of Montreal Can lifted its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 57.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,827 shares of the company’s stock after purchasing an additional 5,047 shares during the period. Bank of Montreal Can’s […]
- 03/18/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Sold by ArrowMark Colorado Holdings LLC
- ArrowMark Colorado Holdings LLC cut its holdings in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 13.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,860,158 shares of the company’s stock after selling 282,727 shares during the period. ArrowMark Colorado […]
- 03/18/2020
|
Consumer Healthcare Market 2020 - Globally Market Size, Analysis, Share, Research, Business Growth and Forecast to 2023 | 360 Research Reports
- Mar 17, 2020 (The Expresswire) --
Global “Consumer Healthcare Market” Report 2020 is a comprehensive, professional report provides a detailed overview of...
- 03/17/2020
|
Chevy Chase Trust Holdings Inc. Purchases Shares of 1,678 Prestige Consumer Healthcare Inc (NYSE:PBH)
- Chevy Chase Trust Holdings Inc. purchased a new stake in Prestige Consumer Healthcare Inc (NYSE:PBH) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,678 shares of the company’s stock, valued at approximately $68,000. Other institutional investors and hedge funds also recently bought and sold […]
- 03/16/2020
|
361 Capital LLC Sells 40,545 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- 361 Capital LLC reduced its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 52.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 36,785 shares of the company’s stock after selling 40,545 shares during the quarter. 361 Capital LLC owned approximately 0.07% of […]
- 03/15/2020
|
Ajo LP Sells 36,459 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- Ajo LP cut its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 25.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 108,167 shares of the company’s stock after selling 36,459 shares during the period. Ajo LP owned approximately 0.22% of Prestige Consumer […]
- 03/13/2020
|
Analysts Expect Prestige Consumer Healthcare Inc (NYSE:PBH) Will Post Quarterly Sales of $237.53 Million
- Equities research analysts expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will announce sales of $237.53 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Prestige Consumer Healthcare’s earnings, with estimates ranging from $235.20 million to $239.10 million. Prestige Consumer Healthcare reported sales of $241.03 million during the same […]
- 03/13/2020
|
Premium Brands Holdings Corporation Announces Record Fourth Quarter and 2019 Sales and Adjusted EBITDA, a 10% Dividend Increase, Three New Business Investments and Guidance for 2020
- Premium Brands Holdings Corporation Announces Record Fourth Quarter and 2019 Sales and Adjusted EBITDA, a 10% Dividend Increase, Three New Business Investments and Guidance for 2020
- 03/12/2020
|
The Dow Is Plunging Again. Stock in Dramamine’s Maker Soared on Tuesday.
- Moves in the futures market pointed to losses for all three of the main U.S. stock indexes as markets continue to churn.
- 03/11/2020
|
Prestige Brands management to meet with William Blair PBH
- Prestige Brands management to meet with William Blair PBH
- 03/10/2020
|
Barclays PLC Increases Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Barclays PLC lifted its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 77.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 89,660 shares of the company’s stock after purchasing an additional 39,027 shares during the quarter. Barclays PLC owned 0.18% of […]
- 03/04/2020
|
Charles Schwab Investment Management Inc. Has $20.61 Million Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Charles Schwab Investment Management Inc. increased its holdings in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 3.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 508,789 shares of the company’s stock after acquiring an additional 19,311 shares during the quarter. Charles Schwab […]
- 03/03/2020
|
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?
- The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
- 03/02/2020
|
Prestige Brands announces new $25M share repurchase plan PBH
- Prestige Brands announces new $25M share repurchase plan PBH
- 03/02/2020
|
Prestige Consumer Healthcare Announces $25M Buyback
|
Prestige Consumer Healthcare Inc. Announces New $25 Million Share Repurchase Program, Participation in the Raymond James Institutional Investors Conference
- Prestige Consumer Healthcare Inc. (PBH) today announced that the Company’s Board of Directors authorized the repurchase of up to $25.0 million of the Company’s issued and outstanding common stock. Separately, the Company plans to present at the Raymond James Institutional Investors Conference at 8:40 a.m. ET today, March 2nd.
- 03/02/2020
|
Study: Gender Diversity In Analytics – 2020
- Women are breaking the glass ceiling across industries and enterprises, rising to the top echelons of company departments and management. Nevertheless, the participation of women in the technology sector, and more specifically across the data science domain, is still significantly constrained by low participation fueled by possible hiring stereotypes and mindsets around women in science…
- 03/02/2020
|
Prestige Consumer Healthcare Inc. Announces New $—5 Million Share Repurchase Program, ...
|
Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Purchased by LSV Asset Management
- LSV Asset Management boosted its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 12.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 660,478 shares of the company’s stock after acquiring an additional 74,700 shares during the period. LSV Asset Management owned about […]
- 02/29/2020
|
M&T Bank Corp Has $344,000 Stock Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
- M&T Bank Corp lowered its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 8.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,495 shares of the company’s stock after selling 820 shares during the quarter. M&T Bank Corp’s holdings in Prestige […]
- 02/29/2020
|
Crossmark Global Holdings Inc. Takes Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Crossmark Global Holdings Inc. acquired a new stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,940 shares of the company’s stock, valued at approximately $241,000. Several other hedge funds and […]
- 02/26/2020
|
Eagle Asset Management Inc. Has $10.34 Million Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Eagle Asset Management Inc. increased its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 20.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,272 shares of the company’s stock after buying an additional 43,603 shares during the quarter. […]
- 02/24/2020
|
Jennison Associates LLC Trims Stock Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
- Jennison Associates LLC lowered its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 0.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 440,612 shares of the company’s stock after selling 4,202 shares during the period. Jennison Associates LLC’s holdings in Prestige Consumer Healthcare were […]
- 02/23/2020
|
State of Tennessee Treasury Department Sells 75,285 Shares of Prestige Consumer Healthcare Inc (NYSE:PBH)
- State of Tennessee Treasury Department trimmed its holdings in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 54.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 62,714 shares of the company’s stock after selling 75,285 shares during the quarter. State of Tennessee […]
- 02/21/2020
|
Kevin O'Leary's 10 Favorite Quality Dividend Stocks - Sure Dividend
- Kevin O'Leary, better known as Mr. Wonderful, is one of the world's most famous investors. These 10 dividend stocks are among Mr. Wonderful's favorites.
- 02/21/2020
|
PBH vs. UNICY: Which Stock Should Value Investors Buy Now?
- PBH vs. UNICY: Which Stock Is the Better Value Option?
- 02/20/2020
|
PBH vs. UNICY: Which Stock Should Value Investors Buy Now?
- PBH vs. UNICY: Which Stock Is the Better Value Option?
- 02/20/2020
|
Turtle Creek Asset Management Inc. Buys Gildan Activewear Inc, Alliance Data Systems Corp, ...
|
Cherry Healey is asked most about Gregg Wallace - and he's "not what you think"
- Cherry Healey, 39, on how she takes care of herself, the new series of 10 Years Younger In 10 Days, and wanting to see more women are TV who are not looking their best…
- 02/16/2020
|
Prestige Consumer Healthcare Inc (NYSE:PBH) to Post FY2020 Earnings of $2.87 Per Share, DA Davidson Forecasts
- Prestige Consumer Healthcare Inc (NYSE:PBH) – Equities researchers at DA Davidson upped their FY2020 earnings estimates for shares of Prestige Consumer Healthcare in a research note issued on Friday, February 7th. DA Davidson analyst L. Weiser now expects that the company will post earnings of $2.87 per share for the year, up from their previous […]
- 02/12/2020
|
Edited Transcript of PBH earnings conference call or presentation 6-Feb-20 1:30pm GMT
- Q3 2020 Prestige Consumer Healthcare Inc Earnings Call
- 02/11/2020
|
Prestige Consumer Healthcare Inc. Released Earnings Last Week And Analysts Lifted Their Price Target To US$43.00
- Shareholders of Prestige Consumer Healthcare Inc. (NYSE:PBH) will be pleased this week, given that the stock price is...
- 02/10/2020
|
Will Prestige Consumer Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.
- 02/10/2020
|
Will Prestige Consumer Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.
- 02/10/2020
|
Will Prestige Consumer Continue to Surge Higher?
|
Prestige Consumer Healthcare (NYSE:PBH) Releases FY 2020
Pre-Market Earnings Guidance
- Prestige Consumer Healthcare (NYSE:PBH) issued an update on its FY 2020 Pre-Market earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.85-2.87 for the period, compared to the Thomson Reuters consensus estimate of $2.82. The company issued revenue guidance of $947-957 million, compared to the consensus revenue estimate of $950.49 […]
- 02/09/2020
|
Prestige Consumer Healthcare's (PBH) "Neutral" Rating Reiterated at DA Davidson
- DA Davidson reissued their neutral rating on shares of Prestige Consumer Healthcare (NYSE:PBH) in a research note issued to investors on Friday morning, Stock Target Advisor reports. DA Davidson also issued estimates for Prestige Consumer Healthcare’s FY2020 earnings at $2.87 EPS and FY2021 earnings at $3.04 EPS. A number of other brokerages have also recently […]
- 02/08/2020
|
Prestige Consumer (PBH) Up on Q3 Earnings Beat & Raised View
- Prestige Consumer's (PBH) third-quarter fiscal 2020 results reflect strength in the International segment and robust consumption trends at core brands. However, retailer inventory reductions persist.
- 02/07/2020
|
Prestige Consumer (PBH) Up on Q3 Earnings Beat & Raised View
- Prestige Consumer's (PBH) third-quarter fiscal 2020 results reflect strength in the International segment and robust consumption trends at core brands. However, retailer inventory reductions persist.
- 02/07/2020
|
Prestige Consumer Healthcare (NYSE:PBH) Trading 8.4% Higher Following Strong Earnings
- Prestige Consumer Healthcare Inc (NYSE:PBH)’s stock price traded up 8.4% during mid-day trading on Thursday following a stronger than expected earnings report. The stock traded as high as $45.29 and last traded at $44.99, 2,045,300 shares changed hands during trading. An increase of 371% from the average session volume of 433,876 shares. The stock had […]
- 02/07/2020
|
Prestige Brands Clears Key Benchmark, Hitting 90-Plus RS Rating
|
